NCT02172196View on ClinicalTrials.gov

Bioavailability of BI 10773 and Sitagliptin in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

July 31, 2009

Conditions
Healthy
Interventions
DRUG

BI 10773

DRUG

Sitagliptin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02172196 - Bioavailability of BI 10773 and Sitagliptin in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter